查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945402

2026年全球介入性腫瘤消融市場報告

Interventional Tumor Ablation Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，介入性腫瘤消融市場發展迅速，預計將從2025年的17.7億美元成長到2026年的19.3億美元，複合年成長率達8.5%。過去幾年的成長可歸因於全球癌症發生率的上升、醫學影像技術的進步、微創療法日益受到青睞、介入性腫瘤學實踐的擴展以及消融手術臨床療效的改善。

預計未來幾年介入性腫瘤消融市場規模將維持強勁成長，2030年將達到26.6億美元，複合年成長率（CAGR）為8.5%。預測期內的成長要素包括人工智慧輔助影像引導技術的日益普及、個人化癌症治療的廣泛應用、門診手術中心的擴張、腫瘤設備創新投資的增加以及對經濟高效癌症治療方法日益成長的需求。預測期內的主要趨勢包括微創腫瘤消融手術的日益普及、影像引導消融技術的日益廣泛應用、微波和射頻消融術系統的擴展、對門診癌症治療需求的成長以及對精準腫瘤學的日益重視。

預計未來幾年，癌症發生率的不斷上升將推動介入性腫瘤消融市場的成長。癌症是一組疾病，其特徵是異常細胞不受控制地生長和擴散，這些細胞可以侵入周圍組織，並透過血液和淋巴系統轉移到身體的其他部位。癌症發生率的上升主要歸因於生活方式和環境因素，例如吸煙、不健康飲食、肥胖以及接觸致癌性。介入性腫瘤消融術透過提供一種微創的治療方法傳統手術的方案來輔助癌症治療。這些技術能夠精準地摧毀腫瘤，縮短治療和恢復時間，並改善患者的預後和生活品質。例如，根據聯合國專門機構世界衛生組織（世衛組織）的數據，截至2024年2月，預計到2025年，全球新增癌症病例將超過3,500萬例，比2022年估計的2,000萬例增加77%。因此，癌症發生率的上升正在推動介入性腫瘤消融市場的擴張。

為了提高手術精準度並改善治療效果，介入性腫瘤消融市場的主要企業正致力於開發先進的技術解決方案，例如BioTrace軟體套件。 BioTrace軟體套件是一個整合平台，旨在追蹤、管理和分析生物學和臨床數據，尤其適用於醫療和研究環境。例如，2024年7月，總部位於以色列的醫療設備製造商TechsoMed Medical Technologies Ltd.宣布推出BioTraceIO Vision和BioTraceIO Precision，這兩款軟體解決方案專為影像導引的肝腫瘤消融治療而開發。 BioTraceIO Vision利用基於標準醫學影像的人工智慧驅動的個人化治療計畫和評估工具，以提高肝腫瘤​​消融的精確度和效率。同時，BioTraceIO Precision可在手術過程中和術後提供基於超音波的消融區域即時可視化和預測性映射。這使得臨床醫生能夠評估組織損傷和治療效果，並且已被證明與消融後24小時的電腦斷層掃描結果高度相關。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球介入性腫瘤消融市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 自主系統、機器人與智慧運輸
  • 主要趨勢
    • 微創腫瘤消融手術的應用日益增多
    • 影像導引消融技術的應用日益廣泛
    • 擴展微波和射頻消融術系統
    • 門診癌症治療的需求不斷成長
    • 日益關注精準腫瘤學

第5章 終端用戶產業市場分析

  • 醫院
  • 癌症治療中心
  • 門診手術中心
  • 研究所
  • 專科診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球介入性腫瘤消融市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球介入性腫瘤消融市場規模、對比及成長率分析
  • 全球介入性腫瘤消融市場表現：規模與成長，2020-2025年
  • 全球介入性腫瘤消融市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依手術類型
  • 微創手術，影像導引治療
  • 透過技術
  • 射頻消融術（RFA）、微波消融術（MWA）、冷凍療法、雷射消融術、高強度聚焦超音波（HIFU）
  • 依設備類型
  • 消融系統、耗材、輔助設備、診斷影像系統
  • 按應用程式字段
  • 肝臟腫瘤、腎臟腫瘤、肺部腫瘤、骨骼腫瘤
  • 最終用戶
  • 醫院、專科癌症治療中心、門診手術中心及研究機構
  • 按類型細分：微創手術
  • 經皮腫瘤消融術、內視鏡消融術
  • 按類型細分：影像導引治療
  • CT引導腫瘤消融術、MRI引導腫瘤消融術、超音波引導腫瘤消融術

第10章 區域與國家分析

  • 全球介入性腫瘤消融市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球介入性腫瘤消融市場：依國家分類、績效及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 介入性腫瘤消融市場：競爭格局及市場佔有率（2024年）
  • 介入性腫瘤消融市場：公司估值矩陣
  • 介入性腫瘤消融市場：公司概況
    • Johnson & Johnson
    • Medtronic plc
    • Siemens Healthineers AG
    • Stryker Corporation
    • Boston Scientific Corporation

第37章：其他領先和創新企業

  • Olympus Corporation, Terumo Corporation, EDAP TMS SA, Elekta AB, AngioDynamics Inc., InSightec Ltd., Cascination AG, IceCure Medical Ltd., Theraclion SA, Mermaid Medical Group A/S, HS Hospital Service SpA, Varian Medical Systems Inc., Neuwave Medical, BTG plc, MedWaves Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年介入性腫瘤消融市場：提供新機會的國家
  • 2030年介入性腫瘤消融市場：充滿新機會的細分市場
  • 2030年介入性腫瘤消融市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MITAU01_G26Q1

Interventional tumor ablation is a minimally invasive procedure that utilizes image-guided techniques to target and destroy cancerous or benign tumors without the need for open surgery. It uses thermal or non-thermal energy to eliminate tumor cells while minimizing damage to surrounding healthy tissue. This procedure is often employed when surgery is not viable or as an alternative to traditional treatments.

The main product types in interventional tumor ablation include open surgery, minimally invasive surgery, and image-guided interventions. Open surgery involves making an incision in the body to access and treat the affected area, typically using scalpels and other instruments. Key technologies in this field include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, laser ablation, and high-intensity focused ultrasound (HIFU). Device types used in these procedures include ablation systems, consumables, support devices, and imaging systems. Tumor ablation is frequently applied to liver, kidney, lung, and bone tumors. The end users of these technologies range from hospitals and specialized cancer treatment centers to ambulatory surgical centers and research institutes.

Tariffs are influencing the interventional tumor ablation market by increasing costs of imported ablation probes, imaging systems, electronic control units, and specialized medical components used in rfa, mwa, cryoablation, and hifu systems. Hospitals and cancer centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces cost pressure on device exports. These tariffs are increasing capital expenditure and slowing equipment replacement cycles. However, they are also encouraging local manufacturing, regional device assembly, and innovation in cost-optimized ablation technologies.

The interventional tumor ablation market research report is one of a series of new reports from The Business Research Company that provides interventional tumor ablation market statistics, including interventional tumor ablation industry global market size, regional shares, competitors with a interventional tumor ablation market share, detailed interventional tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the interventional tumor ablation industry. This interventional tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional tumor ablation market size has grown strongly in recent years. It will grow from $1.77 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising global cancer incidence, advancement of medical imaging technologies, increasing preference for minimally invasive therapies, expansion of interventional oncology practices, improved clinical outcomes of ablation procedures.

The interventional tumor ablation market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing integration of ai-assisted imaging guidance, rising adoption of personalized cancer treatment, expansion of ambulatory surgical centers, growing investments in oncology device innovation, increasing demand for cost-effective cancer therapies. Major trends in the forecast period include increasing adoption of minimally invasive tumor ablation procedures, rising use of image-guided ablation technologies, expansion of microwave and radiofrequency ablation systems, growing demand for outpatient cancer treatments, enhanced focus on precision oncology.

The increasing incidence of cancer is expected to drive the growth of the interventional tumor ablation market in the coming years. Cancer encompasses a group of diseases marked by the uncontrolled growth and spread of abnormal cells, which can invade surrounding tissues and spread to other parts of the body through the blood and lymphatic systems. The rising occurrence of cancer is largely attributed to lifestyle and environmental factors, including smoking, unhealthy diets, obesity, and exposure to carcinogenic substances. Interventional tumor ablation supports cancer treatment by providing minimally invasive therapeutic options that serve as alternatives to conventional surgery. These techniques shorten treatment durations and recovery times by enabling precise tumor destruction, thereby improving patient outcomes and quality of life. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, more than 35 million new cancer cases are projected globally by 2025, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising incidence of cancer is contributing to the expansion of the interventional tumor ablation market.

Leading companies operating in the interventional tumor ablation market are concentrating on the development of advanced technological solutions, such as BioTrace software suites, to improve procedural accuracy and enhance treatment effectiveness. BioTrace software suites are integrated platforms designed to track, manage, and analyze biological and clinical data, particularly within healthcare and research settings. For example, in July 2024, TechsoMed Medical Technologies Ltd., an Israel-based medical device manufacturer, introduced BioTraceIO Vision and BioTraceIO Precision, software solutions developed for image-guided liver tumor ablation therapy. BioTraceIO Vision utilizes artificial intelligence-driven personalized treatment planning and assessment tools based on standard medical imaging to increase the precision and efficiency of liver tumor ablation. BioTraceIO Precision offers real-time ultrasound-based visualization and predictive mapping of the ablation zone during and after procedures, enabling clinicians to evaluate tissue damage and treatment outcomes with strong correlation to 24-hour post-ablation computed tomography scans.

In February 2024, Immunophotonics Inc., a US-based biotechnology company, entered into a partnership with AngioDynamics Inc. This collaboration is intended to combine Immunophotonics' lead immunotherapy candidate, IP-001, with AngioDynamics' ablation technologies to investigate the potential of integrating ablation with immunotherapy for the treatment of solid tumor cancers. AngioDynamics Inc. is a US-based medical device company that provides microwave and radiofrequency ablation systems for minimally invasive cancer therapies.

Major companies operating in the interventional tumor ablation market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, EDAP TMS S.A., Elekta AB, AngioDynamics Inc., InSightec Ltd., Cascination AG, IceCure Medical Ltd., Theraclion SA, Mermaid Medical Group A/S, H.S. Hospital Service S.p.A., Varian Medical Systems Inc., Neuwave Medical, BTG plc, MedWaves Inc., Perseon Medical AB, Chongqing Haifu Medical Technology Co. Ltd., AngioDynamics Nanoknife Division, Galil Medical Inc.

North America was the largest region in the interventional tumor ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional tumor ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the interventional tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The interventional tumor ablation market consists of revenues earned by entities by providing services such as electroporation, tumor biopsy services, thermal ablation monitoring, and post-ablation follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional tumor ablation market also includes sales of radiofrequency ablation (RFA) generators, microwave ablation (MWA) systems, cryoablation probes, laser fibers and electrode needles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Tumor Ablation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses interventional tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional tumor ablation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Procedure Type: Minimally Invasive Surgery; Image-Guided Interventions
  • 2) By Technology: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)
  • 3) By Device Type: Ablation Systems; Consumables; Support Devices; Imaging Systems
  • 4) By Application Area: Liver Tumors; Kidney Tumors; Lung Tumors; Bone Tumors
  • 5) By End User: Hospitals; Specialized Cancer Treatment Centers; Ambulatory Surgical Centers; Research Institutes
  • Subsegments:
  • 1) By Minimally Invasive Surgery: Percutaneous Tumor Ablation; Endoscopic Ablation
  • 2) By Image-Guided Interventions: Computed Tomography-Guided Tumor Ablation; Magnetic Resonance Imaging-Guided Tumor Ablation; Ultrasound-Guided Tumor Ablation
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; EDAP TMS S.A.; Elekta AB; AngioDynamics Inc.; InSightec Ltd.; Cascination AG; IceCure Medical Ltd.; Theraclion SA; Mermaid Medical Group A/S; H.S. Hospital Service S.p.A.; Varian Medical Systems Inc.; Neuwave Medical; BTG plc; MedWaves Inc.; Perseon Medical AB; Chongqing Haifu Medical Technology Co. Ltd.; AngioDynamics Nanoknife Division; Galil Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Interventional Tumor Ablation Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Interventional Tumor Ablation Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Interventional Tumor Ablation Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Interventional Tumor Ablation Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Tumor Ablation Procedures
    • 4.2.2 Rising Use Of Image-Guided Ablation Technologies
    • 4.2.3 Expansion Of Microwave And Radiofrequency Ablation Systems
    • 4.2.4 Growing Demand For Outpatient Cancer Treatments
    • 4.2.5 Enhanced Focus On Precision Oncology

5. Interventional Tumor Ablation Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cancer Treatment Centers
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Research Institutes
  • 5.5 Specialty Clinics

6. Interventional Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Interventional Tumor Ablation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Interventional Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Interventional Tumor Ablation Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Interventional Tumor Ablation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Interventional Tumor Ablation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Interventional Tumor Ablation Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Interventional Tumor Ablation Market Segmentation

  • 9.1. Global Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Minimally Invasive Surgery, Image-Guided Interventions
  • 9.2. Global Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
  • 9.3. Global Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ablation Systems, Consumables, Support Devices, Imaging Systems
  • 9.4. Global Interventional Tumor Ablation Market, Segmentation By Application Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liver Tumors, Kidney Tumors, Lung Tumors, Bone Tumors
  • 9.5. Global Interventional Tumor Ablation Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialized Cancer Treatment Centers, Ambulatory Surgical Centers, Research Institutes
  • 9.6. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Minimally Invasive Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Percutaneous Tumor Ablation, Endoscopic Ablation
  • 9.7. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Image-Guided Interventions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Computed Tomography-Guided Tumor Ablation, Magnetic Resonance Imaging-Guided Tumor Ablation, Ultrasound-Guided Tumor Ablation

10. Interventional Tumor Ablation Market Regional And Country Analysis

  • 10.1. Global Interventional Tumor Ablation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Interventional Tumor Ablation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Interventional Tumor Ablation Market

  • 11.1. Asia-Pacific Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Interventional Tumor Ablation Market

  • 12.1. China Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Interventional Tumor Ablation Market

  • 13.1. India Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Interventional Tumor Ablation Market

  • 14.1. Japan Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Interventional Tumor Ablation Market

  • 15.1. Australia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Interventional Tumor Ablation Market

  • 16.1. Indonesia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Interventional Tumor Ablation Market

  • 17.1. South Korea Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Interventional Tumor Ablation Market

  • 18.1. Taiwan Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Interventional Tumor Ablation Market

  • 19.1. South East Asia Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Interventional Tumor Ablation Market

  • 20.1. Western Europe Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Interventional Tumor Ablation Market

  • 21.1. UK Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Interventional Tumor Ablation Market

  • 22.1. Germany Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Interventional Tumor Ablation Market

  • 23.1. France Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Interventional Tumor Ablation Market

  • 24.1. Italy Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Interventional Tumor Ablation Market

  • 25.1. Spain Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Interventional Tumor Ablation Market

  • 26.1. Eastern Europe Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Interventional Tumor Ablation Market

  • 27.1. Russia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Interventional Tumor Ablation Market

  • 28.1. North America Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Interventional Tumor Ablation Market

  • 29.1. USA Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Interventional Tumor Ablation Market

  • 30.1. Canada Interventional Tumor Ablation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Interventional Tumor Ablation Market

  • 31.1. South America Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Interventional Tumor Ablation Market

  • 32.1. Brazil Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Interventional Tumor Ablation Market

  • 33.1. Middle East Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Interventional Tumor Ablation Market

  • 34.1. Africa Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Interventional Tumor Ablation Market, Segmentation By Procedure Type, Segmentation By Technology, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Interventional Tumor Ablation Market Regulatory and Investment Landscape

36. Interventional Tumor Ablation Market Competitive Landscape And Company Profiles

  • 36.1. Interventional Tumor Ablation Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Interventional Tumor Ablation Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Interventional Tumor Ablation Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Interventional Tumor Ablation Market Other Major And Innovative Companies

  • Olympus Corporation, Terumo Corporation, EDAP TMS S.A., Elekta AB, AngioDynamics Inc., InSightec Ltd., Cascination AG, IceCure Medical Ltd., Theraclion SA, Mermaid Medical Group A/S, H.S. Hospital Service S.p.A., Varian Medical Systems Inc., Neuwave Medical, BTG plc, MedWaves Inc.

38. Global Interventional Tumor Ablation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Interventional Tumor Ablation Market

40. Interventional Tumor Ablation Market High Potential Countries, Segments and Strategies

  • 40.1 Interventional Tumor Ablation Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Interventional Tumor Ablation Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Interventional Tumor Ablation Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer